1. Dr Lal PathLabs Q4 net profit up 20 pct at Rs 34.44 crore

Dr Lal PathLabs Q4 net profit up 20 pct at Rs 34.44 crore

Diagnostic chain Dr Lal PathLabs today reported 19.79 per cent rise in consolidated net profit at Rs 34.44 crore for the quarter ended March 31, 2016.

By: | New Delhi | Published: May 27, 2016 6:03 PM
dr lal path lab ipo The company had posted a net profit of Rs 28.75 crore for the corresponding period of the previous fiscal, Dr Lal PathLabs said in a filing to BSE.

Diagnostic chain Dr Lal PathLabs today reported 19.79 per cent rise in consolidated net profit at Rs 34.44 crore for the quarter ended March 31, 2016.

The company had posted a net profit of Rs 28.75 crore for the corresponding period of the previous fiscal, Dr Lal PathLabs said in a filing to BSE.

Consolidated total income from operations rose to Rs 197.71 crore for the quarter under consideration as against Rs 171.84 crore for the year ago period.

For the fiscal year ended March 31, 2016, the company posted a net profit of Rs 132.19 crore against Rs 95.69 crore for the year ago fiscal.

Consolidated total income from operations of the company stood at Rs 791.32 crore for the recently ended fiscal. It was Rs 659.59 crore for the previous fiscal year.

In a separate filing the company said its board has recommended a dividend of Rs 2.45 per equity share of Rs 10 each for the year ended March 31, 2016.

Shares of Dr Lal PathLabs today closed at Rs 949.50 per scrip on BSE, down 3.20 per cent from its previous close.

  1. No Comments.

Go to Top